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Abstract
Background: Mitochondrial biogenesis is under the control of two different genetic systems: the nuclear genome (nDNA)
and the mitochondrial genome (mtDNA). The mtDNA is a circular genome of 16.6 kb encoding 13 of the approximately 90
subunits that form the respiratory chain, the remaining ones being encoded by the nDNA. Eukaryotic cells are able to
monitor and respond to changes in mitochondrial function through alterations in nuclear gene expression, a phenomenon
first defined in yeast and known as retrograde regulation. To investigate how the cellular transcriptome is modified in
response to the absence of mtDNA, we used Affymetrix HG-U133A GeneChip arrays to study the gene expression profile of
two human cell lines, 143BTK
2 and A549, which had been entirely depleted of mtDNA (ru cells), and compared it with that
of corresponding undepleted parental cells (r
+ cells).
Results: Our data indicate that absence of mtDNA is associated with: i) a down-regulation of cell cycle control genes and a
reduction of cell replication rate, ii) a down-regulation of nuclear-encoded subunits of complex III of the respiratory chain
and iii) a down-regulation of a gene described as the human homolog of ELAC2 of E. coli, which encodes a protein that we
show to also target to the mitochondrial compartment.
Conclusions: Our results indicate a strong correlation between mitochondrial biogenesis and cell cycle control and suggest
that some proteins could have a double role: for instance in controlling both cell cycle progression and mitochondrial
functions. In addition, the finding that ELAC2 and maybe other transcripts that are located into mitochondria, are down-
regulated in ru cells, make them good candidates for human disorders associated with defective replication and expression
of mtDNA.
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Introduction
Mitochondria are double-membrane cytoplasmic organelles
that house a number of fundamental cellular pathways and
functions, including, the aerobic synthesis of ATP [1]; the
biosynthesis of heme, ketones, and uridine [2], calcium trafficking,
and control of apoptosis [3]. Since reactive oxygen species (ROS)
are by-products of respiration, mitochondria are also the major
source of ROS, being equipped with protective systems to prevent
damage determined by these harmful compounds.
Mitochondria have their own DNA [4]: the human mitochon-
drial genome (mtDNA) is a 16.6 kb double-stranded circular DNA
molecule encoding 13 of the approximately 90 subunits that form
the respiratory chain, the remaining ones being encoded by the
nuclear genome (nDNA). These latter proteins are synthesized in
the cytoplasm and imported into mitochondria where they are
assembled, together with the mitochondrially encoded subunits, to
form the respiratory chain complexes of the inner mitochondrial
membrane [5].
While important factors involved in mtDNA expression and
replication have been identified in humans, little is known about
the molecular mechanisms regulating the nuclear-mitochondrial
cross-talk. Eukaryotic cells are able to monitor and respond to
changes in mitochondrial function through alterations in nuclear
gene expression, a phenomenon first defined in yeast and known
as retrograde regulation [6]. To investigate the nuclear response to
impairment of mitochondrial function, a commonly applied
method involves the use of so-called ru cell lines, i.e. cells that
have been completely depleted of mtDNA by prolonged exposure
to sub-lethal doses of ethidium bromide (EthBr). For instance,
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the transcriptome of a human breast cancer cell line and its ru
derivative and found deregulation of a number of different genes
involved in pathways as diverse as cell signalling, metabolism, cell
growth and differentiation. Behan et al. [8] used Affymetrix
technology to study the nuclear gene expression response to the
lack of mitochondrial DNA in ru and r
+ (i.e. non-depleted
parental) Nawalma cells. According to their analysis the most
affected cellular functions were exemplified by genes involved in
hypoxic response, glycolysis and fatty acid oxidation and genes
encoding mitochondrial ribosomal proteins, transport channels
and tRNA synthases. More recently, Magda et al. [9] used
Affymetrix microarrays to compare ru and r
+ A549 lung cancer
cells grown either in culture or as xenografts in nude mice. Results
from that study showed that mtDNA levels regulated the
expression of genes involved in glucuronydation, tRNA synthetase,
immune surveillance and peroxisomal lipid metabolism. Although
these studies proved valuable insights into the complexity of the
nuclear response to the absence of mtDNA, their different results
also emphasize the difficulty in identifying common signatures of
mtDNA depletion across various model systems. The partially
non-overlapping results reported in above-cited studies may be
attributed either to the use of different microarray platforms and
analysis methods or to the use of different cell lines and growth
conditions. Cell-type specific effects had already been reported by
quantitative transcription analysis of a selected number of nuclear
genes across two different human ru cell lines, their r
+
counterparts, and fibroblasts from a patient affected by Kearns-
Sayre syndrome (KSS) [10]. Furthermore, growth conditions
proved to have a higher influence on gene expression profiles than
the effect of mtDNA depletion itself [9].
To identify which nuclear transcripts are subjected to
retrograde regulation in human cells regardless of the specific cell
type, we performed a comparative microarray analysis of global
RNA expression profiles in two immortal human cell lines and in
their ru cell derivatives. Using a stringent statistical approach, we
identified 191 genes the expression of which was significantly and
consistently different in both ru cell lines compared with their
parental cell lines.
Results and Discussion
Gene expression profiling of human ru cell lines
In order to minimize cell line-specific effects on nuclear
transcription due to EthBr treatment, we compared the expression
profiles obtained from two different cell lines, 143BTK
2
osteosarcoma cells and A549 lung adenocarcinoma cells, to that
of their mtDNA-less (ru) derivatives. The latter were generated
with no clonal selection (see Materials and Methods), in order to
dilute any possible effect due to chromosomal aneuploidy, which
can occur in cancer-derived cultured cells. Three independent
biological replicates were used for each cell type. The method
adopted to identify differentially expressed genes takes into
account the variance-versus-mean dependence that exists in
microarray data, which typically follows a power law [11]. Using
the Power Law Global Error Model (PLGEM) analysis method,
selection of significant changes in gene expression is intrinsically
more stringent for transcripts with very low expression levels, than
for transcripts with high expression levels [11]. Due to high noise
of microarray data and to the relatively small sample size in
comparison to the number of analyzed genes, our approach was
mainly aimed at limiting the amount of false predictions. A total of
191 genes (Table S1) were identified as differentially expressed in
both cell lines: 88 genes in common were up-regulated while 103
in common were down-regulated (Figure 1). Only ,30 genes were
expected to be selected by chance using this statistical technique
(see Materials and Methods for details).
In order to determine whether our gene cohort was significantly
enriched in gene products associated with specific molecular
functions, sub-cellular compartments or biological processes, we
analyzed the functional annotations of the 191 differentially
expressed transcripts by using their associated Gene Ontology
(GO) terms. The most significantly enriched GO terms were used
as a guide to manually assemble a functional classification of the
differentially expressed genes, grouping together terms with similar
biological function. Four main functional categories were
identified in this way (Figure 1 and Table S2): genes encoding
mitochondrial proteins (16 entries), genes involved in protein
synthesis (14 entries), genes involved in cell cycle and chromatin
structure (12 entries) and genes involved in mRNA processing (4
entries).
Validation of microarray data by real-time PCR and
Western blot
We confirmed the results obtained by microarray analysis by
quantitative RT-PCR (real-time PCR) on a limited number of
genes. The absence of mtDNA and mitochondrial specific
transcripts was demonstrated in ru cells by quantitative PCR
(data not shown). As reported in Figure 2A, five gene-products
whose differential expression passed the statistical test (RIS1,
ANT3, PHB, ATP5D, ELAC2) in microarray experiments, also
showed significantly different expression levels by RT-PCR. On
the contrary, expression of genes involved in mtDNA transcription
(such as TFAM) and replication (such as SSBP1, POLG1 and
PEO1) that did not pass the statistical test, for instance because of
a ‘‘No Change’’ call in either one of the microarray replicates, was
also unchanged by real-time PCR (data not shown).
The Rieske iron-sulfur protein, a component of the complex III
of the respiratory chain, was found significantly down-regulated by
microarray analysis in both ru cell lines. Marked reduction of the
corresponding protein was confirmed by Western blot analysis on
SDS PAGE (Figure 2B). Conversely, transcripts of complex III
10 kDa subunit and complex III assembly factor BCS1L, were
unchanged in the microarray data and the corresponding proteins
were found unchanged by Western blot analysis (Figure 2B).
Differential effects on complex V and complex III in cells
lacking mtDNA
Table S2 reports 16 differentially expressed nuclear genes
coding for mitochondrial proteins. Both ‘‘up’’ and ‘‘down’’
changes were detected in ru vs. r
+ cells. For instance, the
transcripts of ATP5D, which is part of the F1 particle of the ATP
synthase (complex V), and isoform 3 of the adenine nucleotide
translocator (ANT3) were both up-regulated (+30–40%) by
microarray and RT-PCR analysis (Figure 2A). ru cells retain
both an aurovertin-sensitive ATPase activity, provided by the F1
particle, and an adenine nucleotide translocation activity, carried
out by the three ANT isoforms [12]. These activities are essential
to maintain the mitochondrial membrane potential, prevent
osmotic swelling of the organelle and avoid apoptosis due to
cytochrome c release [13].
As already mentioned, an opposite effect was observed in genes
encoding subunits of the complex III, for instance, transcription of
the Rieske iron-sulphur protein [14] was down by 60–70%. This
phenomenon was specific because the expression of other genes
encoding for respiratory chain complexes was unaltered. Complex
III (Ubiquinol cytochrome c reductase), is a 250 kDa homodimer,
Expression Profile of ru Cells
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mtDNA encoded cytochrome b. The Rieske protein plays a major
role in complex III function; by transferring electrons from
ubiquinol to cytochrome b and from cytochrome c1 to cytochrome
c. Western blot confirmed a profound reduction of the Rieske
protein in both ru cell types (Figure 2B). Although the mRNA
Figure 2. Validation of microarray data. (A) Comparison between relative mRNA changes predicted by microarray and those verified by RT-PCR
analysis, in either A549 or 143BTK2 cells. Bars represent average relative expression changes of the genes indicated at the bottom, comparing ru cells
vs. r+ controls across three biological replicates. (B) Western blot analysis on r+ and ru cell lysates of complex III subunits (Rieske, Core 1, Core2, and
10 kDa subunits) and of the assembly factor BCS1L. To normalize for the protein content in each lane an SDH specific antibody was used as a
mitochondrial standard.
doi:10.1371/journal.pone.0005713.g002
Figure 1. Microarray data analysis strategy. A schematic overview of the strategy used to identify genes commonly up- or down-regulated in ru
cells is given (see Materials and Methods for details).
doi:10.1371/journal.pone.0005713.g001
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2 and the 10 kDa subunit) were not significantly changed by
microarray analysis, Core 1 and Core 2 were significantly
decreased at the protein level whereas the 10 kDa subunit was
not (Figure 2B). However, it has to be considered that the level of
mRNA expression does not directly correlate with the amount of
the corresponding protein. This is particularly true for the
OXPHOS apparatus, since the stability of each single complex
is strongly influenced by the stability of the others. Although we
did not carry out Western blot analysis on all the nuclear-encoded
protein subunits forming the OXPHOS complexes, we observed
that the absence of assembled complex III in ru cells is associated
with degradation of some of its protein components. On the other
hand, the BCS1L protein that is responsible for the insertion of the
Rieske protein into the pre-complex III, as one of the last steps in
complex III assembly [15], is present in comparable amounts in
both ru and r
+ cells according to microarray data and Western
blot analysis (Figure 2B). This indicates that the lack of structural
complex III subunits does not determine a decreased production
of the BCS1L protein, suggesting either a mechanism of
compensation in the absence of complex III subunits or an
additional function for BCS1L unrelated to complex III assembly.
Complex III is the major site of ROS production during
hypoxia and plays a central role in the oxygen-sensing pathway
[16,17]. ROS have been demonstrated to modulate respiration in
mammals by regulating several checkpoints energy pathways and
mtDNA homeostasis. Since respiration-incompetent ru cells fail to
generate ROS, an attractive hypothesis prompted by our
observation is that ROS control on respiration could be mediated,
at least in part, by modulating the expression of the Rieske protein
and the activity of complex III.
Absence of mtDNA delays cell cycle progression
We observed a generalized down-regulation of genes involved in
the control of cell cycle (Tables S1 and S2), including H2AFZ and
H2AFX, two members of the histone family H2A, cyclin E2, and
Histone deacetylase 1 (HDAC1), which play an important role in
both transcriptional regulation and cell cycle progression [18].
Interestingly, down-regulation of HDAC1 can explain that of
cyclin E2, since it is known that HDAC1 inhibition alters the
expression of several genes including cyclin E [19]. Recent studies
report for mitochondria a role in the regulation of cell growth and
differentiation [20,21,22]. To investigate whether down-regulation
of cell-cycle genes could affect growth and proliferation rate, cells
were counted daily for 5 days. The doubling time of ru cells
derived from both 149BTK
2 and A549 cell lines was significantly
longer (30 and 39 hrs) than that of their parental r
+ cells (23 and
29 hours (Figure 3). Our results are in agreement with recent data
by Magda et al. on A549 cells [9] and by Schauen et al. obtained
in ru HeLa cells [22].
A link between cell-cycle control and mitochondrial biogenesis
is suggested by the observation that transcripts for two mitochon-
drial proteins, prohibitin (PHB) [23] and C1QBP/p32 [24] were
both down regulated in ru cell lines. PHB acts as a chaperone
protein, is essential for normal mitochondrial biogenesis in C.
elegans, [25], and plays a role as a regulator of cell-cycle progression
[26,27,28]. Recently Merkwirth and Langer demonstrated that
mitochondrial prohibitin complexes control cell proliferation,
cristae morphogenesis and the functional integrity of mitochondria
[29]. C1QBP/p32 is mainly localized to the mitochondrial matrix
[30], but a small fraction is also present in the nucleus, which
suggests a role for p32 as a factor mediating nucleus-mitochondrial
crosstalk. Nuclear p32 is believed to be involved in the control of
cell growth and cell cycle via the MAP kinase pathway [31].
Taken together, these data suggest the existence of a cross-talk
between the nuclear and the mitochondrial genome that slows
down cell cycle progression in case of mitochondrial defects.
Schauen et al. ruled out energetic or metabolic impairment as the
direct cause of the reduced cell proliferation of ru HeLa cells,
whereas they attributed it to a reduction of ROS generation and
p21
CIP1/WAF1 expression. Future work is warranted to elucidate
whether this, or an alternative mechanism, is implicated in the
down-regulation of cell cycle control factors observed by us.
Identification of a novel mitochondrial transcript down-
regulated by lack of mtDNA
Among the poorly characterized genes found to be down-
regulated in ru cells, shown by microarray analysis, and confirmed
by RT-PCR, we focused our attention on ELAC2 [32], which was
first identified as a prostate cancer susceptibility gene [33]. Elac2 is
the human homolog of tRNase Z in E. coli, which is responsible for
the endonucleolytic cleavage of the 39 end of tRNAs.
The Elac2 N-terminus scores high for mitochondrial targeting
when analyzed by ad hoc prediction softwares (Mitoprot, Predotar,
TargetP, PSORT), consistent with the idea that Elac2 might be
imported into mitochondria. To test this hypothesis experimen-
tally we carried out Western blot analysis on sub-cellular fractions
(Figure 4A–B), by using a commercially available anti-Elac2
polyclonal antibody. The specificity of the Elac2 antibody was
tested by immuno-detection of an in-vitro translated product
corresponding to the human ELAC2 cDNA (Figure 4A, lane i.v.).
An Elac2 specific CRM (Cross-Reacting Material), was present in
isolated mitochondria and in mitochondrial fractions (matrix and
membrane in Figure 4A), but was also detected, although at low
level, in the nucleus. We also demonstrated that Elac2 is located
inside the organelle since treatment with proteinase K (pK) failed
to digest the protein in intact mitochondria, while it underwent
complete digestion after solubilization of mitochondrial mem-
branes with Triton X-100 (Figure 4B).
In order to understand if the N-terminus of Elac2 contained a
cleavable mitochondrial targeting peptide, we generated a
recombinant short version of Elac2 flagged with the HA epitope
on the C-terminus (see Methods). This construct was used to
transfect Cos7 cells (Cos-7
Elac2-HA) and to perform in vivo
immunoprecipitation (Figure 4C) and immunofluorescence studies
(Figure 4D).
Using an anti-HA antibody, two
35S radiolabeled protein bands
were immunoprecipitated from a lysate of Cos-7
Elac2-HA cells. The
size of the higher molecular weight band (Figure 4C) corresponds
to a protein of 36.5 kDa, which we believe is the mitochondrial
precursor protein, while the lower molecular weight band of
approximately 34.7 kDa corresponds to the mature mitochondrial
Elac2 (mElac2) species, generated by enzymatic cleavage of the
aminoterminal leader peptide from the precursor (Figure 4C).
Since import is dependent on the presence of the mitochondrial
transmembrane electrochemical gradient, only the band corre-
sponding to the precursor was present after incubation with
valinomycin, a mitochondrial ionophore that destroys the
mitochondrial membrane potential. The size difference between
the two bands suggests that the leader peptide encompasses the
first 16 aminoacid residues, as predicted by TargetP. The
mitochondrial localization of Elac2 was further confirmed by the
coincidence of the Elac2-HA immunofluorescence pattern with
that of mtSSB, a mitochondrial matrix protein (Figure 4D).
Our results, and the similarity of Elac2 with tRNAse Z, suggest
for this protein a function in mitochondrial tRNA processing. This
hypothesis has been confirmed for TRZ1, the yeast homologue of
mammalian Elac2 [34] and for the RNaseZ of Drososphila
Expression Profile of ru Cells
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mitosis in S. cerevisiae [36]. Therefore, down-regulation of Elac2
expression may be involved in the delay of cell cycle and reduced
proliferation rate observed in ru cells. In addition, Elac2 over-
expression may alter mitotic progression in HeLa cells possibly by
interacting with the c-tubulin complex [37]. Finally, Elac2 has
been located also in the nucleus [38], suggesting for this protein
additional functions, including a role in nuclear-mitochondrial
cross-communication.
Additional considerations
Depletion of mtDNA has been correlated with chromosomal
instability in 143B cell lines [39]. Although we did not perform a
detailed karyotyping of the cell lines used in the present study,
there is a straightforward way to check for possible chromosome
copy number changes from gene expression microarray data. On
average, expression of genes on aneuploid chromosomes has been
shown to scale linearly with chromosome copy number in both
yeast and mammalian cells [40,41]. However, the average gene
expression change was similar across all chromosomes in both our
143BTK
2 ru cells and our A549 ru cells compared to their
parental counterparts (Figure S1). Looking at gene expression
ratios as a function of chromosomal coordinate, we also did not
detect any significant segmental copy number changes (data not
shown). Although this analysis cannot rule out the possibility for
chromosomal translocations, it excludes that mtDNA depletion
induced stable and clonal aneuploidies in our cell lines. It is still
formally possible, though less likely, that the cell populations used
for this microarray analysis were composed of a heterogeneous
mixture of cells with different aneuploidies that could have
cancelled each other out (i.e. for every cell that gained a particular
chromosome there could have been another cell that lost that same
chromosome). Either way, aneuploidies would not have signifi-
cantly affected the gene expression profiles described in this report.
Due to the remarkable contribution of cell-type specific effects
on the transcriptional response of cells to mtDNA depletion, it was
difficult for us to compare our gene expression signatures with
previously reported microarray data obtained from human ru cell
lines. The closest match we were able to find is with the report
from Magda et al. [9], which used a cell line similar to one of ours
Figure 3. Reduced cell proliferation of ru cells Cell proliferation curves of 143BTK2 (A) and A549 cells (B) are shown. Closed symbols,
r+ cells; open symbol, ru cells. Points and error bars respectively represent the mean and the standard deviation of three independent experiments.
doi:10.1371/journal.pone.0005713.g003
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U133A). Of the 131 genes reported to be up-regulated in A549 ru
vs. r
+ cells in their study, 24 (,18%) were found also among the
up-regulated genes in the same cells in this study. Of the 145
down-regulated genes in their report, 51 (,35%) were found also
in ours. The relatively low overlap could be explained by the
different cell culture conditions used to grow the cells (different
growth medium and glucose concentration), the different time
span given to the cells to adapt to the ru status (freshly derived ru
cells in their case, well established ru lines in ours) or to the
different statistical analysis methods used to detect the differen-
tially expressed genes.
To our surprise, no genes involved in replication and
transcription of mtDNA, were present in the output of our
analysis. This could be due to the fact that: 1) these genes could
have an expression level that was below the threshold of sensitivity
of the method, or 2) these genes behave differently either in the
different cell lines or in one of the three replicates. However, since
we analyzed two different cell lines that were subjected to the same
treatment to eliminate the mtDNA and that were maintained in
culture using exactly the same growth medium and conditions, the
genes selected by this analysis could be considered as a bona fide set
of genes differentially expressed in reply to the absence of mtDNA.
Conclusions
Absence of mtDNA in human cells triggers a complex nuclear
gene expression response, particularly as regarding genes involved
in cell cycle control and mitochondrial functions. Our analysis also
suggests that some genes could have a double role in both
mitochondrial functions and in other cellular processes. For
instance, prohibitin (PHB), C1QBP/p32 and Elac2 are part of the
mitochondrial proteome and are also involved in the control of cell
cycle progression. Likewise, BCS1L – which is clearly involved in
complex III assembly – has also been suggested to play a role in
iron metabolism and possibly other metabolic pathways [42].
In prohibitin knock-down cells, the mtDNA copy number is
decreased [43], suggesting that this protein is a candidate for
human conditions associated with mtDNA depletion [44].
Likewise, Elac2 could be involved in mitochondrial disorders
associated with defects of mtDNA transcription and translation.
Figure 4. Mitochondrial localization of Elac2. (A) Sub-organellar localization of Elac2 by western-blot analysis on mitochondria isolated from
HeLa cells. Specificity of antibody reactivity was proved by the CRM obtained using an in vitro translated (i.v.) Elac2. A CRM was present in
mitochondria (M), in the mitochondrial matrix (Ma) and membranes (Mb), and barely detectable in the nucleus (N). ETHE1 antibody was used as a
mitochondrial matrix control protein. (B) Proteinase K protection assay by western-blot analysis on freshly isolated mitochondria from HeLa cells. Lane
1, cell lysate; lane 2, intact mitochondria; lane 3, mitochondria treated with 100 mg/ml of proteinase K; lane 4, mitochondria treated with 0.5% of
Triton-X100. (C) Mitochondrial in vivo import of HA-tagged human Elac2 N-terminal polypeptide expressed in Cos-7 cells. Lane 1: marker 46 kDa
(MW). lane 2: immunoprecipitation of total radiolabeled proteins. lane 3: immunoprecipitation of total radiolabeled proteins after the addition of
valinomycin that determines the elimination of the mitochondrial DY: as a consequence, mitochondrial import is abolished. lane 4:
immunoprecipitation of in vitro translation product (i.v.). Arrows indicate the Elac2 precursor (Elac2) and the mature form (mElac2). (D) Confocal
immunofluorescence on Cos7 cells. The green fluorescence corresponds to Elac2HA-specific immunoreactivity. The red fluorescence corresponds to
immunoreactivity specific to mtSSB. The two immunofluorescence patterns overlap, as shown by confocal merge. Magnification: 406.
doi:10.1371/journal.pone.0005713.g004
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Cell lines and EthBr treatment
All cells were maintained in a 5% CO2 humidified atmosphere
at 37uC. 143BTK
2 osteosarcoma cell line and A549 lung
carcinoma cell line (a kind gift of Dr. Ian Holt), were grown for
3–4 weeks in Dulbecco’s modified Eagle medium (DMEM), high-
glucose (Euroclone), supplemented with 10% Fetal Calf Serum
(FCS), 1 mM NaPyruvate and 50 mg/ml uridine. To generate ru
cells we added 50 ng/ml ethidium bromide (EthBr) to the growth
medium, for a period of 3 weeks. No clone selection was
performed but the cells were trypsinised and pooled together.
One week after the removal of EthBr, absence of mtDNA was
checked in ru cell lines by either PCR or by Southern blot.
143BTK
2, A549 and their ru derivatives were stored in liquid
nitrogen until needed for experiments. They were then revived
and grown for around 10 passages to isolate RNA for microarray
analysis. Absence of mtDNA was checked by PCR before each
experiment.
Cell growth
Cells were plated at a density of 2,000 cells per cm
2 and grown
in complete DMEM medium. At selected intervals cells were
harvested by trypsinization and counted using the Trypan Blue
vital staining. Growth rate was calculated by determining the
duplication time [45].
cRNA preparation and microarray hybridization
RNA samples for microarray analysis were prepared according
to the manufacturer’s recommendations. Briefly, total RNA was
isolated from 8610
6 cells using the Qiagen RNeasy Mini kit
(Qiagen); 12 mg of total RNA was then used to generate double-
stranded cDNA using an oligo (dT24) primer containing a T7
polymerase recognition sequence. The cDNA was then used as a
template for in vitro transcription reaction (BioArray High Yield
RNA transcript labelling kit ENZO) using biotinylated CTP and
UTP to produce labelled cRNA. The cRNA was then fragmented
and hybridized to HG-U133A GeneChip arrays (Affymetrix,
Santa Clara, CA), which contain 22,283 probe sets designed to
interrogate the expression of more than 13,000 unique human
genes. Hybridized chips were then washed and stained with
streptavidin-phycoerytherin and scanned with an Affymetrix
GeneChip scanner. Resulting image files were processed by
Affymetrix Microarray Suite 5.0 (MAS5) to compute probe set-
specific expression values, e.g. Signal, Detection, etc. Three
independent RNA extractions were performed for each cell lines
(both for parental and for n ˜u derivatives), reaching a total of 12
microarrays. The microarray dataset was deposited in the public
Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.
gov/geo/) under accession number GSE14900.
Data pre-processing and identification of differentially
expressed genes
The data set containing expression values for 22,283 probe sets
and 12 samples was analyzed inside the R environment [46]
mainly using packages from the BioConductor project [47]. First,
a ‘‘quantile normalization’’ [48] was applied to each of the two
subsets of data corresponding to a given cell line, independently.
Then, genes called ‘‘Absent’’ by MAS5 across all six samples of a
given cell line were removed, leaving 14,012 and 13,096 probe sets
in the 143BTK
2 and the A549 dataset, respectively. The
intersection between these two sets was of 12,031 probe sets.
Microarray data from the three biological replicates available for
each ru cell line were then compared to the three biological
replicates of the corresponding parental cells using the BioCon-
ductor package ‘‘plgem’’ [11]. A PLGEM was fitted on an
independent data set, containing Affymetrix HG-U133A data
from eight distinct individuals, which had been pre-processed in
the same way as the data reported in the present work. Resulting
model parameters were used to calculate model-based signal-to-
noise statistics when comparing ru cells versus parental cells.
Genes were selected as differentially expressed in a particular cell
line, if their observed signal-to-noise ratio was more extreme than
the 5% most extreme statistics values observed during a series of
1,000 random re-samplings performed on the set of data set used
to fit the model.
Though the two differential expression analyses performed
independently on 143BTK
2 and on A549 cells were run using
quite relaxed stringency parameters (per-gene significance lev-
el=0.05), a reduction of the false positive rate is expected when
combining results from two independent analyses. Despite the
impossibility to report an accurate p-value of the combined result, it
is possible to speculate the following. In the case that not a single
gene was actually differentially expressed, ,700 genes
(=14,01260.05) and ,655 genes (=13,09660.05) would be
expected to be selected by chance alone in the 143BTK
2 and the
A549 dataset, respectively. Instead, 548 were selected as up-
regulated and 674 genes were selected as down-regulated in the
143BTK
2 dataset, whereas 1,504 were up- and 1,354 were down-
regulated in the A549 dataset (Figure 1A). Under the same null
hypothesis, and considering a complete independence between the
two analyses, the total number of false positive genes in the
combined result should drop down to ,30 (=12,03160.0560.05),
while in fact 88 genes were found as commonly up-regulated and
103 as commonly down-regulated in the two cell lines (Figure 1A).
Functional categories enrichment evaluation
The list of 191 probe sets was first converted into the
corresponding 180 unique Entrez Gene IDs [49] and then analyzed
with the function ‘‘GOHyperG’’ from the BioConductor package
‘‘GOstats’’ that uses the hypergeometric distribution to evaluate
enrichment of particular Gene Ontology functional categories [50].
An independent analysis was performed for each of the three
ontologies currently supported by the GO project, i.e molecular
function, biological process, and cellular component [51].
Quantitative RT-PCR
Total RNA was prepared from 8610
6 cells using the RNeasy kit
(Qiagen). Superscript reverse transcriptase II (Invitrogen), was
used to produce cDNA starting from 12 mg of total RNA. RT-
PCR was carried out using an Applied Biosystem Inc. (ABI) Prism
7000 Sequence Detection real-time system in a two-step reaction.
Primers for the genes of interest are reported in Table 1 and were
designed using the ABI Prism Primer Express (2.0) software. All
primers were checked by BLAST search against the mRNA
database to ensure, specific homology, only to the gene of interest.
Each PCR reaction was performed in triplicate in 50 ml with
600 mM (final concentration) each of the forward and reverse
primers, and 25 mlo f2 6 SYBR green PCR Master Mix (ABI)
with the following profile: one cycle at 50uC for 2 min, one cycle at
95uC for 10 min, and then 40 cycles of 95uC for 15 s, 60uC for
1 min (two-step protocol). We chose as the endogenous control the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene.
Western blot analysis and antibodies
Approximately 2610
6 cells were trypsinized, pelleted, sonicated,
and solubilized as previously described. SDS-polyacrylamide gel of
100–200 mg protein/lane, and Western blot analysis were
Expression Profile of ru Cells
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antibody against BCS1L was obtained from ProteinTech Group,
Inc (Chicago). The monoclonal antibodies against RIS1, Core1,
and Core2 were from Invitrogen. The monoclonal antibody
against the 10 kDa subunit was from MitoSciences. In order to
check for equal amount of proteins for all samples, the blot was
stripped and re-probed with an SDH specific polyclonal antibody
(Invitrogen). A mouse monoclonal antibody against the haemoag-
glutinin epitope of the influenza virus (anti-HA) was from Roche.
An affinity purified polyclonal antibody against ELAC2 was from
ProteinTech, while the polyclonal antibody against Ethe1 was
raised in rabbit by Neosystem [52].
Mitochondrial targeting
Immunofluorescence (IF) was carried out on coverslip-plated
cells. Cells were fixed and incubated with a polyclonal antibody
specific to mtSSB and with a monoclonal anti-HA antibody
(Roche). Fluorescent-dye conjugated secondary antibodies were
used as previously described [53]. IF was visualised using a
confocal microscope (Biorad). In vivo import was performed as
described [52].
Cell fractionation
Standard methods were used for the preparation of mitochon-
drial fractions in cultured cells [54]. For sub-organellar localiza-
tion, freshly isolated mitochondria from HeLa cells were treated
with three cycles of freezing and thawing and six sonication strokes
on ice-cold water. The membrane and soluble fractions were then
separated by ultracentrifugation at 100,0006g for 1 hr at 4uC. For
proteinase K protection, mitochondria were incubated with
100 mg/ml of proteinase K for 20 min at 37uC, with and without
the addition of 0.5% Triton X-100.
Generation and cloning of ELAC2
HA
A full-length human ELAC2 cDNA clone was obtained from the
RZPDconsortium (clone IRALp962C132Q).The first 970 bp onthe
59 end of the human ELAC2 cDNA were tagged on the 39 end with
the HA epitope. The following oligonucleotides were used for PCR
reaction using the RZPD clone as a template. Underlined sequence




Each of the 30 PCR amplification cycles was 95uC for 1 min, 70uC
for 2 min.The cDNA was cloned into the plasmid vectorTA-cloning
TOPO II kit (Invitrogen) and sequenced. The cDNA was then
inserted into the eukaryotic expression plasmid vector pcDNA3.1
(Invitrogen) using suitable restriction sites. The predicted chimeric
protein has an expected molecular weight of 36.5 kDa.
Supporting Information
Figure S1 Distribution of gene expression changes per chromo-
some. Gene expression log2 ratios from the 143BTK2 ru vs. r+
cells (upper panel) or from the A549 ru vs. r+ cells (lower panel)
were subdivided based on chromosome and their distributions
shown as box-and-whisker plots. Chromosomal location was
obtained from Ensembl version 53 [55] based on the NCBI 36
assembly of the human genome. Only probe sets not called always
‘‘Absent’’ across all samples of the corresponding GeneChip
dataset and that uniquely mapped to a single locus were included
in this analysis. Box-and-whisker plots were generated in R using
default settings, i.e. the thick horizontal line inside the box
represents the median of the distribution, and the lower and upper
hinges of the box represent the first and the third quartile of the
distribution, while the two whiskers extend to 1.5 times the inter-
quartile range of the distribution. Outlier probe sets are plotted as
circles. A red and a blue horizontal line are superimposed to the
plot to show where the average gene expression ratio would be
expected to be found, if the corresponding chromosome was
gained once or lost once, respectively.
Found at: doi:10.1371/journal.pone.0005713.s001 (5.66 MB TIF)
Table S1 191 genes showing consistent and significant differen-
tial expression in ru vs. r+ cells (in both A549 and 143BTK2 cell
lines). Signal, detection and ratio between ru and r+ cells are
reported along with gene names and accession numbers to Entrez
Gene, GenBank and UniGene. A, B and C are the three biological
replicates for each condition.
Found at: doi:10.1371/journal.pone.0005713.s002 (0.20 MB
XLS)
Table S2 Functional classification of differentially expressed
genes. Genes are grouped according to their most likely function,
deduced from Gene Ontology annotations and from data available
in published literature.
Found at: doi:10.1371/journal.pone.0005713.s003 (0.05 MB
XLS)
Table S3 Primers used in the quantitative PCR amplification
analysis
Found at: doi:10.1371/journal.pone.0005713.s004 (0.03 MB
DOC)
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